Tag: Zymeworks
Salud
Zymeworks Announces Release of ESMO Abstract for Phase 1 Study of Zanidatamab Zovodotin (ZW49) in Solid Cancers
Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced the release of an...
Economía
Zymeworks Confirms Receipt of Unsolicited, Non-Binding Proposal from All Blue Falcons
Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today confirmed it has received...
Want to stay up to date with the latest news?
We would love to hear from you! Please fill in your details and we will stay in touch. It's that simple!